A self-motivated, passionate and result-driven scientist with 14 years of biotech industry experience in drug/biomarker discovery. * Successful track record of designing and executing projects from target validation to IND stage. * Led Therapeutic Biology Group for target selection and therapeutic discovery to build pipeline * Develop and implement biomarker/precision medicine strategy from Discovery through Phase I of several programs including ERBB, MAPK and PI3K pathway inhibitors. * Deep expertise in cutting edge technologies including CRISPR/Cas9, next generation sequencing (NGS) and Proteomics. * Proven ability to translate basic research findings to clinical insights including predicting drug response, resistance and progression on therapy. * Led cross-functional R&D teams in functional genomics and single cell RNAseq based cancer immunotherapy programs. * Collaborative team player with experience working on multi-disciplinary project teams. * Authored over 40 publications/patents and presented work at numerous conferences.
Description
